175 filings
8-K
VIVO
Meridian Bioscience Inc.
1 Feb 23
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
12:41pm
8-K
VIVO
Meridian Bioscience Inc.
12 Dec 22
Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger
8:01am
8-K
VIVO
Meridian Bioscience Inc.
22 Nov 22
Meridian Bioscience Reports Fourth Quarter and Full Year Fiscal 2022 Operating Results
8:12am
8-K
VIVO
Meridian Bioscience Inc.
11 Oct 22
Submission of Matters to a Vote of Security Holders
4:55pm
8-K
VIVO
Meridian Bioscience Inc.
30 Sep 22
Other Events
5:27pm
8-K
0kl6qukk
5 Aug 22
Meridian Bioscience Reports Third Quarter Fiscal 2022 Operating Results
8:09am
8-K
heehqirzt8fodxsyx4wv
29 Jul 22
Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay
9:28am
8-K
w0dswet7
7 Jul 22
Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction
9:41am
8-K
s21ii85rrsx
7 Jul 22
Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter
7:32am
8-K
49izh9yckn fyh6a
6 May 22
Meridian Bioscience Reports Record Second Quarter Fiscal 2022 Operating Results
8:09am
8-K
0adjc
2 May 22
Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities
9:16am
8-K
ig3myey63u
7 Apr 22
Meridian Bioscience Announces Preliminary Net Revenues Results for Fiscal 2022 Second Quarter
8:48am
8-K
3yfjxkta55c9qe1pc
22 Feb 22
Meridian Bioscience Names Andy Kitzmiller as Chief Financial Officer
6:30am
8-K
on9vqox
4 Feb 22
Meridian Bioscience Reports Second Best Quarter In Company History
8:13am
8-K
r6skgc
27 Jan 22
Meridian Bioscience Elects John C. McIlwraith New Chairman of the Board
3:44pm
8-K
ams9enp05
2 Dec 21
Meridian Bioscience Announces Retirement of CFO Bryan Baldasare
8:11am
8-K
p8b9qra ef
12 Nov 21
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-year Fiscal 2021 Operating Results and Provides Fiscal 2022 Guidance
7:38am
8-K
evnarf
10 Nov 21
Meridian Bioscience Receives FDA Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
9:03am
8-K
4vakvzsjerglz5fnay
29 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:02pm
8-K
ph8b1pd1y7ctnyz gi
1 Sep 21
Regulation FD Disclosure
4:41pm